Showing results (1711-1720 of 1,738) with videos related to
Sort By:
Pageof 174
Nature Medicine|April 24, 2019
Immunogenic neoantigens derived from gene fusions stimulate T cell responsesWei Yang, Ken-Wing Lee, Raghvendra M Srivastava, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2017
The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell LymphomaJacob D Soumerai, Andrew D Zelenetz, Craig H Moskowitz, et al.JAMA Network Open|January 23, 2023
Evaluation of Proton Therapy Reirradiation for Patients With Recurrent Head and Neck Squamous Cell CarcinomaAnna Lee, Robbie Woods, Amgad Mahfouz, et al.Journal of the National Comprehensive Cancer Network : JNCCN|November 7, 2023
Basal Cell Skin Cancer, Version 2.2024, NCCN Clinical Practice Guidelines in OncologyChrysalyne D Schmults, Rachel Blitzblau, Sumaira Z Aasi, et al.Cancer Research|December 6, 2006
Demonstration of a genetic therapeutic index for tumors expressing oncogenic BRAF by the kinase inhibitor SB-590885Alastair J King, Denis R Patrick, Roberta S Batorsky, et al.Journal of the National Comprehensive Cancer Network : JNCCN|May 11, 2016
Basal Cell Skin Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in OncologyChristopher K Bichakjian, Thomas Olencki, Sumaira Z Aasi, et al.Journal of the National Comprehensive Cancer Network : JNCCN|March 12, 2014
Merkel cell carcinoma, version 1.2014Christopher K Bichakjian, Thomas Olencki, Murad Alam, et al.Journal of the National Comprehensive Cancer Network : JNCCN|June 14, 2014
Dermatofibrosarcoma protuberans, version 1.2014Christopher K Bichakjian, Thomas Olencki, Murad Alam, et al.International Journal of Cancer|February 15, 2021
Any day, split halfway: Flexibility in scheduling high-dose cisplatin-A large retrospective review from a high-volume cancer centerJung Julie Kang, Vatche Tchekmedyian, Nader Mohammed, et al.Journal of the National Comprehensive Cancer Network : JNCCN|December 13, 2021
NCCN Guidelines® Insights: Squamous Cell Skin Cancer, Version 1.2022Chrysalyne D Schmults, Rachel Blitzblau, Sumaira Z Aasi, et al.Pageof 174